Gogin Capital

WAmazing provides free subscriber identification module (SIM) cards that allow foreign travelers to register before their arrival in Japan. Through an app, WAmazing also provides tourists with free internet services of up to 500MB. The service aims to prevent visitors from being locked out of free wifi because of sign-up pages in Japanese that demand a local phone number. WAmazing was founded in 2016 and is based in Tokyo, Japan.

beBit, Inc. is an information technology consulting firm based in Tokyo, Japan, established in 2000. The company specializes in customer experience management and user-centered design support services. By assisting enterprises in identifying digital trends and analyzing shifts in user behavior, beBit helps clients create effective digital solutions and develop omnichannel strategies. This approach enables businesses to capitalize on market opportunities and enhance their overall customer engagement.

PuREC is a developer of a culture technology intended to bring efficacy to the treatment process.The company leverages technology to develop rapidly changing cell therapies and mesenchymal stem cells therapies, enabling clients to fight a variety of diseases and change the future of transplantation medicine.

mAbProtein is a bio-venture firm focused on the research, development, manufacturing, and sale of research reagents, diagnostics, and pharmaceuticals, specifically utilizing innovative antibody production technology. The company aims to develop therapeutic antibodies that address unmet medical needs, particularly in the area of inflammatory diseases. By providing research antibodies and reagents, mAbProtein supports medical professionals in diagnosing and treating a range of diseases, contributing to advancements in medical research and therapeutic applications.

On the way to Sakano deliver vegetables grown without the use of pesticides and chemical fertilizers, aiming to spread agriculture with low environmental impact. We want to make agriculture sustainable and reach a sustainable society.

Monstar Lab, Inc. is a software development firm headquartered in Shibuya-ku, Tokyo, specializing in creating software solutions for consumers. Founded in 2006, the company offers a range of services including project planning, market analysis, design, mobile application and web service development, website design, business applications, mobile games, and legacy migration. Additionally, Monstar Lab provides technology for wearable applications, web marketing, and product localization. With more than 1,200 engineers and creators, the firm operates in 26 cities across 15 countries, including Japan, China, Singapore, the Philippines, Bangladesh, Vietnam, Denmark, the United Kingdom, the Netherlands, the Czech Republic, Germany, and Thailand. Monstar Lab emphasizes access to top talent and specialists worldwide, leveraging its diverse expertise to deliver effective solutions and empower innovators globally.

Kringle Pharma, Inc. is a biopharmaceutical company focused on the research and development of hepatocyte growth factor (HGF) protein medicines and NK4 molecules. Established in 2001 and headquartered in Japan, the company aims to harness the regenerative properties of HGF for various medical conditions, including acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scarring. In addition to HGF, Kringle Pharma develops NK4, which acts as an antagonist to HGF and exhibits anti-cancer properties by inhibiting tumor cell invasion and metastasis. The company's product pipeline includes recombinant human HGF for treating acute renal failure, skin ulcers, and central nervous system disorders, as well as NK4 and NK4 gene therapies for cancer treatment.

PuREC is a developer of a culture technology intended to bring efficacy to the treatment process.The company leverages technology to develop rapidly changing cell therapies and mesenchymal stem cells therapies, enabling clients to fight a variety of diseases and change the future of transplantation medicine.